Sign In
Buy HRTX
$0.496
-0.0012 (-0.241%)
At Close: Jul 31, 2026
Heron Therapeutics (HRTX) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
05:30pm, Friday, 21'st Feb 2020
Heron Therapeutics (HRTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Heron Therapeutics Inc (NASDAQ:HRTX) Shares Bought by Great Lakes Advisors LLC
11:34am, Friday, 21'st Feb 2020
Great Lakes Advisors LLC grew its holdings in shares of Heron Therapeutics Inc (NASDAQ:HRTX) by 0.4% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 259,247 sha
Pacira price target raised to $60 from $54 at Piper Sandler PCRX;HRTX
05:02pm, Thursday, 20'th Feb 2020
Pacira price target raised to $60 from $54 at Piper Sandler Piper Sandler PCRX HRTX
Heron Therapeutics weakness a buying opportunity, says Cowen HRTX
12:49pm, Thursday, 20'th Feb 2020
Heron Therapeutics weakness a buying opportunity, says Cowen Cowen HRTX
The Daily Biotech Pulse: Heron Pain Drug Review Extended, Disappointment For Teva In Tourette Syndrome Study
12:06pm, Thursday, 20'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 19) Adverum Biotechnologies Inc (NASDAQ: ADVM ) Akebia
Needham Maintains Buy on Heron Therapeutics, Lowers Price Target to $48
11:04am, Thursday, 20'th Feb 2020Heron Therapeutics (HRTX) Received its Third Buy in a Row
05:26am, Thursday, 20'th Feb 2020
After Cantor Fitzgerald and Stifel Nicolaus gave Heron Therapeutics (NASDAQ: HRTX) a Buy rating last month, the company received another Buy, this time
Heron Therapeutics (HRTX) Received its Third Buy in a Row
05:26am, Thursday, 20'th Feb 2020
After Cantor Fitzgerald and Stifel Nicolaus gave Heron Therapeutics (NASDAQ: HRTX) a Buy rating last month, the company received another
3 “Strong Buy” Healthcare Stocks With Fast-Approaching Catalysts
11:16pm, Wednesday, 19'th Feb 2020
Healthcare stocks have a reputation of keeping investors on their toes. The possibility of surging price action, or conversely, earth shattering drops is very real, but these movements can come and go
3 "Strong Buy" Healthcare Stocks With Fast-Approaching Catalysts
11:14pm, Wednesday, 19'th Feb 2020
Healthcare stocks have a reputation of keeping investors on their toes. The possibility of surging price action, or conversely, earth shattering drops is
Heron Therapeutics (HRTX) Receives a Buy from Stifel Nicolaus
10:35pm, Wednesday, 19'th Feb 2020
Stifel Nicolaus analyst Derek Archila maintained a Buy rating on Heron Therapeutics (HRTX) today. The company's shares closed last Monday at $21.66.
Heron Therapeutics (HRTX) Receives a Buy from Stifel Nicolaus
10:35pm, Wednesday, 19'th Feb 2020
Stifel Nicolaus analyst Derek Archila maintained a Buy rating on Heron Therapeutics (HRTX – Research Report) today. The company’s shares
Heron Therapeutics shares are trading lower after the company announced the FDA extended the review period for the NDA for HTX-011.
09:38pm, Wednesday, 19'th Feb 2020Heron Therapeutics Announces FDA Extension of Review Period For NDA For HTX-011
09:20pm, Wednesday, 19'th Feb 2020Russell Investments Group Ltd. Acquires 40,797 Shares of Heron Therapeutics Inc (NASDAQ:HRTX)
03:42pm, Wednesday, 19'th Feb 2020
Russell Investments Group Ltd. raised its holdings in Heron Therapeutics Inc (NASDAQ:HRTX) by 63.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commiss
